Column Group III Gp, LP bought $12M of SRZN
owner at Surrozen, Inc./DE. 1,034,482 shares at an average of $11.60, traded Mar 26, 2025, filed Mar 28, 2025.
Score components
- +12Role10% owner
- +25Trade size$12.0M at market
- +10Relative to holdingsHoldings up 272%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.9%, 3m -18.1%, 6m +5.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-047104, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | POpen-market purchase Common Stockindirect: By The Column Group III, LP | +323,886 | $11.60 | $3.8M | 704,332 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Common Stockindirect: By The Column Group III-A, LP | +365,769 | $11.60 | $4.2M | 795,411 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Common Stockindirect: By The Column Group Opportunity III, LP | +344,827 | $11.60 | $4.0M | 344,827 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series A Common Warrantsderivativeindirect: By The Column Group III, LP | -90,897 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series A Common Warrantsderivativeindirect: By The Column Group III, LP | +90,897 | - | - | 90,897 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series A Common Warrantsderivativeindirect: By The Column Group III-A, LP | -102,651 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series A Common Warrantsderivativeindirect: By The Column Group III-A, LP | +102,651 | - | - | 102,651 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series B Common Warrantsderivativeindirect: By The Column Group III, LP | -98,870 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series B Common Warrantsderivativeindirect: By The Column Group III, LP | +98,870 | - | - | 98,870 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series B Common Warrantsderivativeindirect: By The Column Group III-A, LP | -111,656 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series B Common Warrantsderivativeindirect: By The Column Group III-A, LP | +111,656 | - | - | 111,656 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series C Common Warrantsderivativeindirect: By The Column Group III, LP | -352,225 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series C Common Warrantsderivativeindirect: By The Column Group III-A, LP | -397,773 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series D Common Warrantsderivativeindirect: By The Column Group III, LP | -352,225 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | HExpiration of long derivative Series D Common Warrantsderivativeindirect: By The Column Group III-A, LP | -397,773 | - | - | 0 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series E Common Warrantsderivativeindirect: By The Column Group III, LP | +161,943 | - | - | 161,943 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series E Common Warrantsderivativeindirect: By The Column Group III-A, LP | +182,884 | - | - | 182,884 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Series E Common Warrantsderivativeindirect: By The Column Group Opportunity II, LP | +172,414 | - | - | 172,414 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Second Tranche Units (Right to Buy)derivativeindirect: By The Column Group III, LP | +485,830 | - | - | 485,830 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Second Tranche Units (Right to Buy)derivativeindirect: By The Column Group III-A, LP | +548,653 | - | - | 548,653 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Second Tranche Units (Right to Buy)derivativeindirect: By The Column Group Opportunity II, LP | +517,241 | - | - | 517,241 | Mar 28, 2025 |
Related signals
Other insiders at Surrozen, Inc./DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | SRZNsell Surrozen, Inc./DE | TCG Crossover GP II, LLC owner | $6.9M 325,000 shares | -44% | |
| 22Weak | Surrozen, Inc./DE | Yang Li Exec. Vice President, Research | $53k 1,584 shares | -8% | |
| 41Moderate | Surrozen, Inc./DE | Craig C Parker Chief Executive Officer | $151k 4,524 shares | -21% | |
| 33Weak | Surrozen, Inc./DE | Charles O Williams Chief Operating Officer | $68k 2,036 shares | -11% | |
| 40Moderate | SRZNbuy Surrozen, Inc./DE | TCG Crossover GP II, LLC owner | $3.0M 121,881 shares | +18% | |
| 40Moderate | SRZNbuy Surrozen, Inc./DE | TCG Crossover GP II, LLC owner | $1.2M 48,997 shares | +8% | |
| 29Weak | SRZNbuy Surrozen, Inc./DE | TCG Crossover GP II, LLC owner | $445k 18,856 shares | +3% | |
| 19Weak | SRZNbuy Surrozen, Inc./DE | TCG Crossover GP II, LLC owner | $203k 9,357 shares | +1% | |
| 44Moderate | Surrozen, Inc./DE | Column Group III Gp, LP owner | $642k 32,507 shares | +4% | |
| 52Moderate | Surrozen, Inc./DE | Tim Kutzkey director, owner | $642k 32,507 shares | +4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.